Effects of Dynamine Ingestion on Various Indices of Sustained Energy
NCT06048640, Not applicable, Completed, The Center for Applied Health Sciences, LLC
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Dynamine Ingestion on Various Indices of Sustained Energy | ClinicalTrials.gov |
| NCT number | NCT06048640 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 25 participants, actual | ClinicalTrials.gov |
| Lead sponsor | The Center for Applied Health Sciences, LLC | ClinicalTrials.gov |
| Conditions | Energy | ClinicalTrials.gov |
| Interventions | Dynamine (methylliberine) | ClinicalTrials.gov |
| First posted | 2023-09-21 | ClinicalTrials.gov |
| Last updated | 2023-09-22 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Concentration | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Concentration as measured by a 10 cm visual analogue scale, where higher values represent better concentration. | ClinicalTrials.gov |
| Primary | Motivation | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Motivation as measured by a 10 cm visual analogue scale, where higher values represent greater motivation. | ClinicalTrials.gov |
| Primary | Mood | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Mood as measured by a 10 cm visual analogue scale, where higher values represent better mood. | ClinicalTrials.gov |
| Primary | Energy | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Energy as measured by a 10 cm visual analogue scale, where higher values represent increased energy. | ClinicalTrials.gov |
| Primary | Sustained Energy | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Sustained energy as measured by a 10 cm visual analogue scale, where higher values represent increased sustained energy. | ClinicalTrials.gov |
| Primary | Well-being | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Well-being as measured by a 10 cm visual analogue scale, where higher values represent improved feelings of well-being. | ClinicalTrials.gov |
| Primary | Cognitive function | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Cognitive function as measured by the Stroop Test. | ClinicalTrials.gov |
| Primary | Cognitive flexibility | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Cognitive flexibility as measured by the Trail Making Test. | ClinicalTrials.gov |
| Secondary | Systolic blood pressure | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Systolic blood pressure in mm of mercury. | ClinicalTrials.gov |
| Secondary | Diastolic blood pressure | Change from baseline to 60 minutes, 120 minutes, and 180 minutes post-baseline. | Diastolic blood pressure in mm of mercury. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)